Primer set for detecting horse health condition and micro-fluidic chip

By designing LAMP primer sets and microfluidic chips for specific viruses, rapid and accurate detection of Hendra virus, Nipa virus, vesicular stomatitis virus and equine infectious hysteritis virus are achieved, and the existing technology is solved It can detect complex, time-consuming and high false positive problems, and is suitable for grassroots applications.

CN118996010AInactive Publication Date: 2024-11-22CHINA INST OF VETERINARY DRUG CONTROL
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202411251911.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-11-22
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing virus detection methods are complex, time-consuming and have many false positives, which cannot meet the simple, fast and accurate detection needs of disease prevention and control, especially when promoting and applying at the grassroots level, the operation requirements are high.

Method used

A set of LAMP primers targeting Hendra virus, Nipa virus, vesicular stomatitis virus and equine infectious hysteritis virus were designed. Combined with a microfluidic chip, it can achieve rapid detection through fluorescence value changes, shortening reaction time , and reduces the possibility of pollution.

Benefits of technology

It realizes rapid, accurate, high sensitivity and strong specificity detection of the above viruses. It can detect 10 copies of viral nucleic acid in 30 minutes, which is suitable for on-site application and reduces the operational complexity and contamination risks of detectors.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118996010A_ABST
    Figure CN118996010A_ABST
Patent Text Reader

Abstract

The invention provides a primer set for detecting the health condition of horses and a micro-fluidic chip, and belongs to the technical field of biological detection. The invention provides a primer set for detecting the health condition of horses. The primer set comprises an LAMP primer group designed aiming at a Hendea virus, a Nipah virus, a vesicular stomatitis virus and an infectious hysteritis virus of horses. The primer set disclosed by the invention can be combined with a micro-fluidic chip, and judgment can be carried out only through the change of a fluorescence value, so that rapid detection of the Hendea virus, the Nipah virus, the vesicular stomatitis virus and the infectious equine hysteritis virus is realized, the reaction process is greatly accelerated, the time required by the reaction is shortened, and the detection efficiency is improved. 10 copies of virus nucleic acid can be detected within 30 minutes, the accuracy is high, the sensitivity is high, the specificity is strong, and the method has a field application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biological detection, and in particular relates to a primer set and a microfluidic chip for detecting the health condition of horses. Background Art

[0002] Hendra virus (HeV) belongs to the Paramyxoviridae family. Horses infected with Hendra virus will have symptoms such as fever, difficulty breathing, facial swelling, slow movement, and some may even bleed from the mouth and nose and die within a few days. Humans infected with Hendra virus may also suffer from kidney failure, which will affect the respiratory system and lead to death due to inability to breathe.

[0003] Nipah virus (NVD) is a new type of zoonotic virus. It is an RNA virus belonging to the Paramyxoviridae family. It can cause widespread vasculitis. Infected people have symptoms such as fever, severe headache, and meningitis, posing serious harm to humans and animals.

[0004] Vesicular stomatitis virus (VSV) is a viral disease of horses, cattle, and pigs. It is characterized by blisters and erosions on the oral mucosa, teat skin, and hoof crown skin, but mortality is rare. Horses infected with this virus may develop a fever, have difficulty eating, lose weight, or become lame. Infected animals generally recover within a week. The most common complications are secondary local bacterial and fungal infections and mastitis.

[0005] Contagious equine metritis (CEA) is a Gram-negative, microaerophilic bacterium, primarily transmitted through mating, affecting equine animals. It primarily affects breeding mares and is characterized by cervicitis, endometritis, and vaginitis. Stallions are asymptomatic. Latently infected breeding mares and stallions are the source of infection. Besides mating infection, indirect contact transmission via contaminated material can also occur. Stallions infected with this bacterium during mating can develop a carrier state lasting for months or even years.

[0006] Traditional virus detection methods include traditional culture methods (pathogen isolation and identification, morphological identification, and automated identification methods), enzyme-linked immunosorbent assays, nucleic acid probes, and nucleic acid amplification (PCR) techniques. However, these methods all have drawbacks, such as the complexity and cost of electron microscopy, the time-consuming nature of virus isolation and culture, and the high incidence of false positives. PCR, a method widely used in clinical testing in recent years, such as conventional PCR and real-time fluorescence quantitative PCR, plays a significant role in pathogen detection and disease diagnosis. However, these methods generally require sophisticated instruments capable of precise temperature control for advanced and complex analysis, impose high operational requirements on test personnel, and have long reaction times, making them difficult to promote at the grassroots level and failing to meet the requirements for simple, rapid, and accurate testing for disease prevention and control. Summary of the Invention

[0007] The present invention provides a set of primers and a microfluidic chip for detecting the health status of horses, which can simultaneously complete the detection of Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus with high accuracy, high sensitivity and strong specificity.

[0008] The present invention provides a set of primers for detecting the health status of horses, including a LAMP primer set designed for Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus.

[0009] Preferably, the LAMP primer set is designed for the sequences shown in SEQ ID No. 25 to SEQ ID No. 28 of Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus, respectively.

[0010] Preferably, the LAMP primer set designed for Hendra virus includes a forward outer primer HeV-F3, a reverse outer primer HeV-B3, a forward inner primer HeV-FIP, a reverse inner primer HeV-BIP, a forward loop primer HeV-LF, and a reverse loop primer HeV-LB, the nucleotide sequences of which are shown in SEQ ID No. 1 to SEQ ID No. 6, in sequence;

[0011] The LAMP primer set designed for Nipah virus includes a forward outer primer NVD-F3, a reverse outer primer NVD-B3, a forward inner primer NVD-FIP, a reverse inner primer NVD-BIP, a forward loop primer NVD-LF, and a reverse loop primer NVD-LB, the nucleotide sequences of which are shown in SEQ ID No. 7 to SEQ ID No. 12, in sequence;

[0012] The LAMP primer set designed for vesicular stomatitis virus includes a forward outer primer VSV-F3, a reverse outer primer VSV-B3, a forward inner primer VSV-FIP, a reverse inner primer VSV-BIP, a forward loop primer VSV-LF, and a reverse loop primer VSV-LB, the nucleotide sequences of which are shown in SEQ ID No. 13 to SEQ ID No. 18, in sequence;

[0013] The LAMP primer set designed for equine infectious metritis virus includes a forward outer primer CEM-F3, a reverse outer primer CEM-B3, a forward inner primer CEM-FIP, a reverse inner primer CEM-BIP, a forward loop primer CEM-LF, and a reverse loop primer CEM-LB, whose nucleotide sequences are shown in SEQ ID No. 19 to SEQ ID No. 24, respectively.

[0014] Preferably, in the LAMP primer set designed for each virus, the concentration of the forward outer primer is 0.1-1 μM, the concentration of the reverse outer primer is 0.1-5 μM, the concentration of the forward inner primer and the reverse inner primer are both 0.1-5 μM, and the concentration of the forward loop primer and the reverse loop primer are both 0.1-3 μM.

[0015] Preferably, in the LAMP primer set designed for each virus, the concentration of the forward outer primer is 0.3-0.5 μM, the concentration of the reverse outer primer is 1-2 μM, the concentration of the forward inner primer and the reverse inner primer are both 2.4-3.4 μM, and the concentration of the forward loop primer and the reverse loop primer are both 1-2 μM.

[0016] The present invention also provides the use of the primer set in preparing a tool for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus.

[0017] Preferably, the tool comprises a microfluidic chip.

[0018] The present invention also provides a microfluidic chip for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus, wherein LAMP reaction systems for different viruses are respectively prepared in the reaction wells of the microfluidic chip;

[0019] The LAMP reaction system for each virus is calculated in 25 μL and includes: freeze-dried system Mix, the concentration of the forward outer primer is 0.1-1 μM, the concentration of the reverse outer primer is 0.1-5 μM, the concentration of the forward inner primer and the reverse inner primer are both 0.1-5 μM, and the concentration of the forward loop primer and the reverse loop primer are both 0.1-3 μM.

[0020] Preferably, the microfluidic chip includes 8 reaction wells.

[0021] The present invention also provides a kit for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus, comprising the above-mentioned microfluidic chip.

[0022] Preferably, when the microfluidic chip is used for detection, DNA extracted from an oral or nasal swab or a genital tract swab is used as a template.

[0023] Beneficial effects: The present invention provides a set of primers for detecting the health status of horses, including a LAMP primer set designed for Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus. A pair of outer primers, a pair of inner primers and a pair of loop primers are designed for each virus. Due to the addition of the loop primers, the reaction process is greatly accelerated, the time required for the reaction is shortened, and 10 copies of viral nucleic acid can be detected within 30 minutes.

[0024] The primer set described in the present invention can be combined with a microfluidic chip, enabling rapid detection of Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis virus based solely on changes in fluorescence. This method offers high accuracy, sensitivity, and specificity for simultaneous detection, as the entire reaction process does not require opening the lid, significantly reducing the potential for contamination and promising field applications. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 This is a physical image of the microfluidic chip of the present invention. The wells are arranged from left to right as negative control (NC), Hendra virus (HeV), Nipah virus (NVD), vesicular stomatitis virus (VSV), equine infectious metritis virus (CEM), and internal control (IC).

[0026] Figure 2 Negative fluorescence curves of the LAMP method for Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis virus;

[0027] Figure 3 Sensitivity fluorescence curves of the LAMP assay for Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis virus at 10 copies / μL;

[0028] Figure 4 The sensitivity fluorescence curves of the LAMP method for Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis virus at 100 opys / μL are shown;

[0029] Figure 5 The sensitivity fluorescence curves of the LAMP method for Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis virus at 1000 opys / μL are shown;

[0030] Figure 6 This is the NVD simulation sample test result diagram. The left side of the figure represents a concentration of 10 copies / μL, and the right side represents a concentration of 100 copies / μL.

[0031] Figure 7 This is the NVD simulation sample test result diagram. The left side of the figure represents a concentration of 10 copies / μL, and the right side represents a concentration of 100 copies / μL.

[0032] Figure 8 This is the VSV simulation sample test result diagram. The left side of the figure represents a concentration of 10 copies / μL, and the right side represents a concentration of 100 copies / μL.

[0033] Figure 9 This is the CEM simulation sample test result diagram. The left side of the figure represents a concentration of 10 copies / μL, and the right side represents a concentration of 100 copies / μL.

[0034] Figure 10 This is a graph showing the test results for a mixed negative equine oral and vaginal sample. DETAILED DESCRIPTION

[0035] The present invention provides a set of primers for detecting the health status of horses, including a LAMP primer set designed for Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus.

[0036] The present invention preferably designs the LAMP primer set based on the conserved regions of Hendra virus (HeV), Nipah virus (NVD), vesicular stomatitis virus (VSV), and equine infectious metritis virus (CEM).

[0037] Table 1 Target genes of the LAMP primer set of the present invention

[0038]

[0039]

[0040] The LAMP primer set of the present invention includes 4 primer sets, and the nucleotide sequences are shown below:

[0041] Group 1, Hendra virus (HeV) primer set:

[0042] Forward outer primer HeV-F3 (SEQ ID No. 1): TAATAGCCCAGAACTGAGAT;

[0043] Reverse outer primer HeV-B3 (SEQ ID No. 2): GCATGGAACCCACATCTA;

[0044] Forward inner primer HeV-FIP (SEQ ID No. 3): GAAAGCAGCACCAATCTTCATTGAAGTTGACTTTGTTCGCTCTCGATG;

[0045] Reverse inner primer HeV-BIP (SEQ ID No. 4): TCTGATATCAATGTACTCAGAAAGTGATGACAGCTTCTATGTCTGGGT;

[0046] Forward loop primer HeV-LF (SEQ ID No. 5): CTGCACTTGGTGATCTGA;

[0047] Reverse loop primer HeV-LB (SEQ ID No. 6): TGGCGCTTTAATCAGGAG;

[0048] The second group, Nipah virus (NVD) primer set:

[0049] Forward outer primer NVD-F3 (SEQ ID No. 7): GCTAGTGCAGCAACTGCTAC;

[0050] Reverse outer primer NVD-B3 (SEQ ID No. 8): CCGGGTCTCTCTGAATACAT;

[0051] Forward inner primer NVD-FIP (SEQ ID No. 9): CAAACAATGTTAGTTCCCATCTGATGACAACCAAGATAAGGATATTTG;

[0052] Reverse inner primer NVD-BIP (SEQ ID No. 10): ACTTGATGTGATTAGATCTCCGAGGAGATGAGTGTGAAAGCAGCTCCA;

[0053] Forward loop primer NVD-LF (SEQ ID No. 11): GGACTATTAGTAGCTGGT;

[0054] Reverse loop primer NVD-LB (SEQ ID No. 12): TGCCGAGTCAATGAAAGT;

[0055] The third group, vesicular stomatitis (VSV) primer group:

[0056] Forward outer primer VSV-F3 (SEQ ID No. 13): ACCGTTCTGCTGAGGATG;

[0057] Reverse outer primer VSV-B3 (SEQ ID No. 14): AACATATCCACTGCAGCA;

[0058] Forward inner primer VSV-FIP (SEQ ID No. 15): TGATTTTCAAGCCCGTCCAGTAGTGCTTCCCATCTACATCCTAGGTCT;

[0059] Reverse inner primer VSV-BIP (SEQ ID No. 16): ACCAGATTTGAGAGTCTAGTCGAGGTGAAATTTGGATCATTCTCCCAT;

[0060] Forward loop primer VSV-LF (SEQ ID No. 17): CCGTGACTTTAGATCT;

[0061] Reverse loop primer VSV-LB (SEQ ID No. 18): TGGTCTCGACTTCTTT;

[0062] The fourth group, equine contagious metritis (CEM) primer set:

[0063] Forward outer primer CEM-F3 (SEQ ID No. 19): TTTAGGAGTGCTCGCAAGAG;

[0064] Reverse outer primer CEM-B3 (SEQ ID No. 20): GCTTCCCTCTGTCCTGACCA;

[0065] Forward inner primer CEM-FIP (SEQ ID No. 21): CTCGTTGCGGGACTTAACCCAACAAACCGAAACACAGGTGCTG;

[0066] Reverse inner primer CEM-BIP (SEQ ID No. 22): GCACTCTAATGAGACTGCCGGTGACATAAGGGCCATGAGGACT;

[0067] Forward loop primer CEM-LF (SEQ ID No. 23): CGAGCTGACGACAGCCATG;

[0068] Reverse loop primer CEM-LB (SEQ ID No. 24): CGGAGGAAGGTGGGGATGA.

[0069] In the LAMP primer set designed for each virus of the present invention, the concentration of the forward outer primer is preferably 0.1-1 μM, more preferably 0.3-0.5 μM, and most preferably 0.3 μM; the concentration of the reverse outer primer is preferably 0.1-5 μM, more preferably 1-2 μM, and most preferably 2 μM; the concentrations of the forward inner primer and the reverse inner primer are preferably both 0.1-5 μM, more preferably both 2.4-3.4 μM, and most preferably both 2.4 μM; the concentrations of the forward loop primer and the reverse loop primer are preferably both 0.1-3 μM, more preferably both 1-2 μM, and most preferably both 1 μM.

[0070] The present invention also provides the use of the primer set in preparing a tool for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus.

[0071] The tool of the present invention preferably comprises a microfluidic chip.

[0072] The present invention also provides a microfluidic chip for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus, wherein LAMP reaction systems for different viruses are respectively prepared in the reaction wells of the microfluidic chip;

[0073] The LAMP reaction system for each virus is preferably 25 μL, and preferably includes: a freeze-dried system Mix, a forward outer primer concentration of 0.1 to 1 μM, a reverse outer primer concentration of 0.1 to 5 μM, a forward inner primer and a reverse inner primer concentration of 0.1 to 5 μM, and a forward loop primer and a reverse loop primer concentration of 0.1 to 3 μM; more preferably includes: a freeze-dried system Mix, F3 0.3 to 0.5 μM, B3 1 to 2 μM, FIP and BIP 2.4 to 3.4 μM each, LF and LB 1 to 2 μM each. The freeze-dried system Mix used in the present invention is preferably a commercial amplification kit. In the embodiment, the freeze-dried system Mix in the LAMP amplification kit (freeze-dried type) is preferably used as an example for illustration, and the freeze-dried kit is preferably purchased from Beijing Taihao Biotechnology Co., Ltd., and the product number is THR-KZ-8-96.

[0074] The microfluidic chip of the present invention preferably includes 8 reaction holes. Figure 1 As shown,.

[0075] The present invention also provides a kit for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus, comprising the above-mentioned microfluidic chip.

[0076] When the present invention utilizes the microfluidic chip for detection, genes extracted from oral and nasal swabs or reproductive tract swabs are used as templates and placed at 65° C. for 30 minutes.

[0077] To further illustrate the present invention, a primer set and a microfluidic chip for detecting the health status of horses provided by the present invention are described in detail below in conjunction with the examples, but they should not be construed as limiting the scope of protection of the present invention.

[0078] Example 1

[0079] 1 Materials and Methods

[0080] 1.1 Plasmid

[0081] Plasmid: Gene plasmid containing conserved regions of Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis virus (Table 1) (Sangon Biotech)

[0082] 1.2 Reagents and consumables

[0083] The main reagents and consumables used in the embodiments of the present invention are as follows:

[0084] Table 2 Consumables and reagents information

[0085] name Manufacturer Item No. LAMP Amplification Kit (lyophilized) Beijing Tellhow Biotechnology Co., Ltd. THR-KZ-8-96 Microfluidic chip (8 reaction wells) Beijing Tellhow Biotechnology Co., Ltd. THR-XP-S-8-01

[0086] 1.3 Detection method

[0087] LAMP reactions were performed under the following conditions: each 25 μL reaction system contained the following: lyophilized system mix: F3 0.3 μM, B3 2 μM, FIP and BIP 2.4 μM each, and LF and LB 1 μM each. Fluorescence was measured using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) using plasmid DNA from Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis virus as templates.

[0088] 1.4 Negative test

[0089] LAMP reaction was performed in a microfluidic chip using sterile water as a template, and the fluorescence value was detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) to test the negative reaction of the primers.

[0090] Negative test results such as Figure 2 As shown, the negative result of the detection method established by the present invention is good.

[0091] 1.5 Sensitivity test

[0092] Plasmid DNA from Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis was diluted 10-fold in a gradient. Three concentration gradients of 1000 copies / μL, 100 copies / μL, and 10 copies / μL were used for LAMP reaction in a microfluidic chip. The fluorescence value was detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) to test the sensitivity of the detection.

[0093] The sensitivity test results are as follows Figures 3-5 As shown, the detection method established by the present invention has a minimum detection limit of 10 copies of the target nucleic acid within 30 minutes.

[0094] 1.6 Simulation sample test

[0095] Oral and vaginal swab samples were collected from horses and simulated samples were prepared by adding Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis plasmid DNA. Three simulated samples with concentration gradients of 100 copies / μL, 10 copies / μL, and negative were tested in a microfluidic chip. The fluorescence values ​​were detected using a microfluidic nucleic acid analysis system (Beijing Taihao Biotechnology Co., Ltd.) to test the anti-interference performance of the detection system.

[0096] The experimental results of the simulated samples are as follows Figures 6-10 As shown, the detection method established by the present invention has strong detection specificity and high sensitivity in a real sample environment.

[0097] Although the above embodiment provides a detailed description of the present invention, it is only a part of the embodiments of the present invention, not all of the embodiments. People can also obtain other embodiments based on this embodiment without creativity, and these embodiments all fall within the scope of protection of the present invention.

Claims

1. A set of primers for detecting the health of horses, characterized in that: Includes LAMP primer sets designed for Hendra virus, Nipah virus, vesicular stomatitis virus, and equine infectious metritis virus.

2. The primer set according to claim 1, characterized in that: The LAMP primer set is designed for the sequences shown in SEQ ID No. 25 to SEQ ID No. 28 of Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus respectively.

3. The primer set according to claim 1 or 2, characterized in that: The LAMP primer set designed for Hendra virus includes a forward outer primer HeV-F3, a reverse outer primer HeV-B3, a forward inner primer HeV-FIP, a reverse inner primer HeV-BIP, a forward loop primer HeV-LF and a reverse loop primer HeV-LB, the nucleotide sequences of which are shown in SEQ ID No. 1 to SEQ ID No. 6 in sequence; The LAMP primer set designed for Nipah virus includes a forward outer primer NVD-F3, a reverse outer primer NVD-B3, a forward inner primer NVD-FIP, a reverse inner primer NVD-BIP, a forward loop primer NVD-LF and a reverse loop primer NVD-LB, the nucleotide sequences of which are shown in SEQ ID No.7 to SEQ ID No.12 in sequence; The LAMP primer set designed for vesicular stomatitis virus includes a forward outer primer VSV-F3, a reverse outer primer VSV-B3, a forward inner primer VSV-FIP, a reverse inner primer VSV-BIP, a forward loop primer VSV-LF and a reverse loop primer VSV-LB, the nucleotide sequences of which are shown in SEQ ID No. 13 to SEQ ID No. 18 in sequence; The LAMP primer set designed for equine infectious metritis virus includes a forward outer primer CEM-F3, a reverse outer primer CEM-B3, a forward inner primer CEM-FIP, a reverse inner primer CEM-BIP, a forward loop primer CEM-LF and a reverse loop primer CEM-LB, whose nucleotide sequences are shown in SEQ ID No.19 to SEQ ID No.

24.

4. The primer set according to claim 3, characterized in that: In the LAMP primer set designed for each virus, the concentration of the forward outer primer is 0.1-1 μM, the concentration of the reverse outer primer is 0.1-5 μM, the concentration of the forward inner primer and the reverse inner primer are both 0.1-5 μM, and the concentration of the forward loop primer and the reverse loop primer are both 0.1-3 μM.

5. Use of the primer set according to any one of claims 1 to 4 in the preparation of a tool for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus.

6. The use according to claim 5, characterized in that: The tool includes a microfluidic chip.

7. A microfluidic chip for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus, characterized in that: respectively preparing LAMP reaction systems for different viruses in the reaction wells of the microfluidic chip; The LAMP reaction system for each virus is 25 μL, including: freeze-dried system Mix, the concentration of the forward outer primer is 0.1-1 μM, the concentration of the reverse outer primer is 0.1-5 μM, the concentration of the forward inner primer and the reverse inner primer are both 0.1-5 μM, and the concentration of the forward loop primer and the reverse loop primer are both 0.1-3 μM.

8. The microfluidic chip according to claim 7, characterized in that: The microfluidic chip includes 8 reaction holes.

9. A kit for simultaneously detecting Hendra virus, Nipah virus, vesicular stomatitis virus and equine infectious metritis virus, characterized in that: Comprising the microfluidic chip according to claim 7 or 8.

10. The kit according to claim 9, characterized in that: When the microfluidic chip is used for detection, genomic DNA extracted from oral and nasal swabs or reproductive tract swabs is used as a template.

Citation Information

Patent Citations

  • Fluorescent LAMP primer used for detecting vesicular stomatitis virus and detecting method

    CN106591498A

  • Nipah virus detection kit and dedicated primer of same

    CN109022621A

  • RAA primer and probe for detecting hendra virus diseases, and detection method

    CN110951922A

  • Primer composition for differential diagnosis of canine distemper virus, canine adenovirus, canine parainfluenza virus and bordetella and application thereof

    CN116287457A

  • Primer probe group, chip and kit for detecting eight avian infectious disease pathogens and application

    CN118563026A